Global Parkinson's Disease Drugs Market Size, Status and Forecast 2022

 Table of Contents

Global Parkinson's Disease Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Parkinson's Disease Drugs
    1.1  Parkinson's Disease Drugs Market Overview
        1.1.1 Parkinson's Disease Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Parkinson's Disease Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Parkinson's Disease Drugs Market by Type
        1.3.1 Madopar
        1.3.2 Sinemet-CR
        1.3.3 Trastal
        1.3.4 COMT Inhibitor
        1.3.5 Other
    1.4 Parkinson's Disease Drugs Market by End Users/Application
        1.4.1 Under 40 Years Old
        1.4.2 40-65 Years Old
        1.4.3 Above 65 Years Old

2 Global Parkinson's Disease Drugs Competition Analysis by Players
    2.1 Parkinson's Disease Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 GSK
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Novartis
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Boehringer Ingelheim
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Teva Pharmaceutical
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Abbvie
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Merck
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Akorn
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Kyowa Hakko Kirin Pharma
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Astellas Pharma
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Desitin Arzneimittel
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Parkinson's Disease Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Endo Pharmaceuticals
    3.12 F.Hoffmann-La Roche
    3.13 H.Lundbeck
    3.14 Valeant
    3.15 Apokyn
    3.16 Orion
    3.17 Stada Arzneimittel
    3.18 US WorldMeds
    3.19 Valeant Pharmaceuticals

4 Global Parkinson's Disease Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Parkinson's Disease Drugs Market Size by Type (2012-2017)
    4.2 Global Parkinson's Disease Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Parkinson's Disease Drugs in Future
    4.4 Top Consumer/End Users of Parkinson's Disease Drugs

5 United States Parkinson's Disease Drugs Development Status and Outlook
    5.1 United States Parkinson's Disease Drugs Market Size (2012-2017)
    5.2 United States Parkinson's Disease Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Parkinson's Disease Drugs Development Status and Outlook
    6.1 EU Parkinson's Disease Drugs Market Size (2012-2017)
    6.2 EU Parkinson's Disease Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Parkinson's Disease Drugs Development Status and Outlook
    7.1 Japan Parkinson's Disease Drugs Market Size (2012-2017)
    7.2 Japan Parkinson's Disease Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Parkinson's Disease Drugs Development Status and Outlook
    8.1 China Parkinson's Disease Drugs Market Size (2012-2017)
    8.2 China Parkinson's Disease Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Parkinson's Disease Drugs Development Status and Outlook
    9.1 India Parkinson's Disease Drugs Market Size (2012-2017)
    9.2 India Parkinson's Disease Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Parkinson's Disease Drugs Development Status and Outlook
    10.1 Southeast Asia Parkinson's Disease Drugs Market Size (2012-2017)
    10.2 Southeast Asia Parkinson's Disease Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Parkinson's Disease Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Parkinson's Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Parkinson's Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Parkinson's Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Parkinson's Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Parkinson's Disease Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Parkinson's Disease Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Parkinson's Disease Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Parkinson's Disease Drugs Market Size by Application (2017-2022)

12 Parkinson's Disease Drugs Market Dynamics
    12.1 Parkinson's Disease Drugs Market Opportunities
    12.2 Parkinson's Disease Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Parkinson's Disease Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Parkinson's Disease Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Parkinson's Disease Drugs Product Scope
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) (2012-2017)
    Table Global Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Parkinson's Disease Drugs Market Share by Regions in 2016
    Figure United States Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Parkinson's Disease Drugs Market Share by Type in 2016
    Figure Madopar Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Sinemet-CR Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Trastal Market Size (Million USD) and Growth Rate (2012-2017)
    Figure COMT Inhibitor Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Parkinson's Disease Drugs Market Share by Application in 2016
    Table Key Downstream Customer in Under 40 Years Old
    Figure Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate in Under 40 Years Old (2012-2017)
    Table Key Downstream Customer in 40-65 Years Old
    Figure Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate in 40-65 Years Old (2012-2017)
    Table Key Downstream Customer in Above 65 Years Old
    Figure Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate in Above 65 Years Old (2012-2017)
    Table Parkinson's Disease Drugs Market Size (Million USD) by Players (2016 and 2017)
    Figure Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure Parkinson's Disease Drugs Market Size Share by Players in 2017
    Table GSK Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of GSK (2012-2017)
    Figure GSK Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Novartis Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Novartis (2012-2017)
    Figure Novartis Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Boehringer Ingelheim Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
    Figure Boehringer Ingelheim Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Teva Pharmaceutical Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Teva Pharmaceutical (2012-2017)
    Figure Teva Pharmaceutical Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Abbvie Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Abbvie (2012-2017)
    Figure Abbvie Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Merck Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Merck (2012-2017)
    Figure Merck Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Akorn Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Akorn (2012-2017)
    Figure Akorn Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Kyowa Hakko Kirin Pharma Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2012-2017)
    Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Astellas Pharma Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Astellas Pharma (2012-2017)
    Figure Astellas Pharma Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Desitin Arzneimittel Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Desitin Arzneimittel (2012-2017)
    Figure Desitin Arzneimittel Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Endo Pharmaceuticals Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Endo Pharmaceuticals (2012-2017)
    Figure Endo Pharmaceuticals Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table F.Hoffmann-La Roche Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of F.Hoffmann-La Roche (2012-2017)
    Figure F.Hoffmann-La Roche Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table H.Lundbeck Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of H.Lundbeck (2012-2017)
    Figure H.Lundbeck Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Valeant Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Valeant (2012-2017)
    Figure Valeant Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Apokyn Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Apokyn (2012-2017)
    Figure Apokyn Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Orion Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Orion (2012-2017)
    Figure Orion Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Stada Arzneimittel Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Stada Arzneimittel (2012-2017)
    Figure Stada Arzneimittel Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table US WorldMeds Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of US WorldMeds (2012-2017)
    Figure US WorldMeds Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Valeant Pharmaceuticals Basic Information List
    Table Parkinson's Disease Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017)
    Figure Valeant Pharmaceuticals Parkinson's Disease Drugs Business Revenue Market Share in 2016
    Table Global Parkinson's Disease Drugs Market Size (Million USD) by Type (2012-2017)
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2012
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2013
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2014
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2015
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2016
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2017
    Table Global Parkinson's Disease Drugs Market Size (Million USD) by Application (2012-2017)
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2012
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2013
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2014
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2015
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2016
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Parkinson's Disease Drugs
    Figure United States Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Parkinson's Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure United States Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure United States Parkinson's Disease Drugs Market Size Share by Players in 2017
    Figure EU Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Parkinson's Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure EU Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure EU Parkinson's Disease Drugs Market Size Share by Players in 2017
    Figure Japan Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Parkinson's Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Japan Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure Japan Parkinson's Disease Drugs Market Size Share by Players in 2017
    Figure China Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Parkinson's Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure China Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure China Parkinson's Disease Drugs Market Size Share by Players in 2017
    Figure India Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Parkinson's Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure India Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure India Parkinson's Disease Drugs Market Size Share by Players in 2017
    Figure Southeast Asia Parkinson's Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Parkinson's Disease Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Parkinson's Disease Drugs Market Size Share by Players in 2016
    Figure Southeast Asia Parkinson's Disease Drugs Market Size Share by Players in 2017
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Regions (2017-2022)
    Table Global Parkinson's Disease Drugs Market Size (Million USD) by Regions (2017-2022)
    Figure Global Parkinson's Disease Drugs Market Size Share by Regions in 2017
    Figure Global Parkinson's Disease Drugs Market Size Share by Regions in 2022
    Figure United States Parkinson's Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Parkinson's Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Parkinson's Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Parkinson's Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Parkinson's Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Parkinson's Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Parkinson's Disease Drugs Market Size (Million USD) by Type (2017-2022)
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2017
    Figure Global Parkinson's Disease Drugs Market Size Share by Type in 2022
    Table Global Parkinson's Disease Drugs Market Size (Million USD) by Application (2017-2022)
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2017
    Figure Global Parkinson's Disease Drugs Market Size (Million USD) by Application in 2022

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy